Loading
过去 90 天内没有内部人买入。最近一笔披露于 2026年3月09日。
Cosmo Pharmaceuticals N.V.：高管交易动态
Cosmo Pharmaceuticals N.V.是一家医疗保健行业的上市公司。其高管通过SIX SER申报股份交易。2025年10月18日至2026年10月18日，Cosmo Pharmaceuticals N.V.的披露记录中共有4位高管提交的59份申报。
公开市场交易分为21笔买入，合计€613万和38笔卖出，合计€2060万；买方共2位高管，卖方共4位高管。其中2份申报未披露金额。与股份授予不同，公开市场买入由高管本人按市价出资。买方中包括2位高级管理人员。申报中包括金额最大的一笔买入，为€400万，日期2025年12月16日。
数据显示，17笔买入属于多位高管在30天内相继买入的情形。这种重合被称为集群：几个人几乎在同一时间做出了相同的决定。自最近一次公布的买入（2026年3月9日）以来，已有223天。大多数交易在发生当天即公开。在这段时间里，只有高管本人知道这笔交易。单笔卖出说明不了太多：高管卖出也可能是为了缴税、筹措资金或分散资产。
与所在交易所相比（178家公司，中位数9份申报），59份申报的数量高于常态。回溯至覆盖起点2024年，高管共申报25笔买入和39笔卖出。
同一行业的其他公司中，我们的信号近期发现了Anixa Biosciences Inc和Vivos Inc的高管买入。本摘要仅基于SIX SER的披露信息，不预示股价未来走向。
高管申报
64
持股线
暂无
买入金额
€1021万
25 笔 · 全部历史
卖出金额
€2068万
39 笔 · 全部历史
谁在何时交易
买入卖出Anonymous (Executive member of the board of directors / member of senior management)14 笔买入21 笔卖出
Anonymous (Non-executive member of the board of directors)10 笔买入10 笔卖出
Anonymous (a non-executive member of the board of directors)7 笔卖出
内部人买入以来
- Anonymous (Non-executive member of the board of directors)-47.4%入场价 CHF 99.10 · 2026年10月16日 收盘 CHF 52.10
- Anonymous (Executive member of the board of directors / member of senior management)-48.2%入场价 CHF 100.60 · 2026年10月16日 收盘 CHF 52.10
入场价为披露次日收盘价，即读者可操作的第一个价格。价格以上市货币计。过往涨跌不代表未来表现。
分析师共识：看涨还是看跌？
分析师对 Cosmo Pharmaceuticals N.V. 的评级为强烈买入（看涨），基于 5 位分析师。 平均目标价：CHF 122.23。
该评分只在所属市场内对买入进行排名。仅在经过回测的策略范围内的交易所提供建议仓位；其他市场的信号仍处于观察状态。并非投资建议。
基本面评分
在 24,161 家已排名公司中位列第 16,587
39.3
评分 / 100
价值30
质量49
FCF 收益率-2.0%
盈利收益率-0.4%
EV/EBITDA·
ROE-1.2%
毛利率49%
净利率-3.5%
负债/EBITDA0.4x
支柱2/3
透明的价值 + 质量排名，独立于内部人交易信号。
财务数据
财年 2025财年截至 2025年12月 · cache
CHF 52.00
分析师一致预期
5 位分析师强烈买入
CHF 92.42目标价 CHF 122.23(+135%)CHF 162.92
利润表
营业收入CHF 104.2M
毛利CHF 50.6M49% 利润率
EBITDACHF 12M11% 利润率
净利润-CHF 3.6M-6.2% 利润率
估值
PER (forward)14.5x
P/Book1.7x
贝塔1.45
资产负债与现金
市值CHF 893.9M
总负债CHF 4.3M
自由现金流-CHF 17.9M
负债 / 股东权益1%
盈利能力与股权结构
ROE-1.2%
ROA-1.1%
内部人持股 %51.8%
机构持股 %18.4%
最新申报日期：2026年5月11日
申报64 总计
30,000 股@ CHF 5.100.015% 占市值2.5% 占其流量SIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q5B00038
30,000 股@ CHF 5.100.015% 占市值2.5% 占其流量ISIN NL0011832936SIX:T1Q5B00038
10,000 股@ CHF 3.650.0037% 占市值0.6% 占其流量SIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q54000C8
10,000 股@ CHF 3.650.0037% 占市值0.6% 占其流量ISIN NL0011832936SIX:T1Q54000C8
4,000 股@ CHF 99.000.040% 占市值6.3% 占其流量SIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q4L00055
4,000 股@ CHF 99.000.040% 占市值6.3% 占其流量ISIN NL0011832936SIX:T1Q4L00055
10,500 股@ CHF 98.780.10% 占市值16.6% 占其流量SIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q4K00099
10,500 股@ CHF 98.7760.10% 占市值16.6% 占其流量ISIN NL0011832936SIX:T1Q4K00099
7,500 股@ CHF 97.930.074% 占市值11.7% 占其流量SIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q4H00038
7,500 股@ CHF 97.93290.074% 占市值11.7% 占其流量ISIN NL0011832936SIX:T1Q4H00038
8,500 股@ CHF 98.360.084% 占市值13.3% 占其流量SIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q4G00022
8,500 股@ CHF 98.36490.084% 占市值13.3% 占其流量ISIN NL0011832936SIX:T1Q4G00022
30,050 股@ CHF 102.580.31% 占市值49.0% 占其流量SIX:https://www.ser-ag.com/en/resources/notifications-market-participants/management-transactions.html#/transaction-details/T1Q4F000C4
30,050 股@ CHF 102.580.31% 占市值49.0% 占其流量ISIN NL0011832936SIX:T1Q4F000C4
2,886 股@ CHF 92.002.2% 占其流量ISIN NL0011832936SIX:T1Q3900024
标准退出：2026年6月7日 (T+90)
▼
Anonymous (Executive member of the board of directors / member of senior management)
1,000 股@ CHF 114.003.3% 占其流量ISIN NL0011832936SIX:T1Q1L00069
▼
Anonymous (Executive member of the board of directors / member of senior management)
2,000 股@ CHF 109.806.3% 占其流量ISIN NL0011832936SIX:T1Q1G00044
▼
Anonymous (Executive member of the board of directors / member of senior management)
100 股@ CHF 110.400.3% 占其流量ISIN NL0011832936SIX:T1Q1G00010
▼
Anonymous (Executive member of the board of directors / member of senior management)
1,000 股@ CHF 110.503.2% 占其流量ISIN NL0011832936SIX:T1Q1G00028
▼
Anonymous (Executive member of the board of directors / member of senior management)
1,000 股@ CHF 107.203.1% 占其流量ISIN NL0011832936SIX:T1Q1F00012
▼
Anonymous (Executive member of the board of directors / member of senior management)
500 股@ CHF 106.401.5% 占其流量ISIN NL0011832936SIX:T1Q1E00015
▼
Anonymous (Executive member of the board of directors / member of senior management)
500 股@ CHF 107.001.5% 占其流量ISIN NL0011832936SIX:T1Q1E00064
▼
Anonymous (Executive member of the board of directors / member of senior management)
1,000 股@ CHF 107.003.1% 占其流量ISIN NL0011832936SIX:T1Q1D00041
▼
Anonymous (Executive member of the board of directors / member of senior management)
1,000 股@ CHF 108.503.1% 占其流量ISIN NL0011832936SIX:T1Q1700046
▼
Anonymous (Executive member of the board of directors / member of senior management)
1,000 股@ CHF 108.303.1% 占其流量ISIN NL0011832936SIX:T1Q1600022
64 条申报中的 25 条
关于 Cosmo Pharmaceuticals N.V.
Cosmo Pharmaceuticals N.V. 是一家生物制药公司，专注于开发胃肠道疾病的治疗方法。该公司在瑞士证券交易所XSWX上市。
同行业近期入选信号
我们的模型当前为推荐列表排序的买入。
全部推荐
